<DOC>
	<DOCNO>NCT02583828</DOCNO>
	<brief_summary>This randomize clinical trial investigate efficacy letrozole combine metronomic oral cyclophosphamide elderly metastasis breast cancer patient .</brief_summary>
	<brief_title>Study Letrozole Combined With Metronomic Oral Cyclophosphamide Elderly Metastasis Breast Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<criteria>Histologically confirm metastatic breast cancer patient estrogen receptor positive and/or progesterone receptor positive ; Elderly woman ( age â‰¥ 65years ) Failure relapse standard chemotherapy unfit chemotherapy Measurable disease per Response Evaluation Criteria Solid Tumors ( RECIST ) ; Eastern Cooperative Oncology Group ( ECOG ) performance status 02 ; Adequate bone marrow , liver renal function ; Estimated life expectancy least 3 month . Serious uncontrolled concurrent medical illness Uncontrolled primary metastatic brain tumor History second primary malignancy Having enrol clinical trial within month</criteria>
	<gender>Female</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>